SlideShare une entreprise Scribd logo
1  sur  16
Inhibitory effect on arterial injury-induced
neointimal formation
by adoptive B cell transfer in Rag-1 KO mice
P. Dimayuga, B. Cercek, S. Oguchi, G. N. Fredrikson,
J. Yano, P. K. Shah, S. Jovinge, J. Nilsson
Department of Medicine, Lund University, University Hospital MAS, Malmö, Sweden
Atherosclerosis Research Center, Cedars-Sinai Medical Center, Los Angeles, California;
Department of Biomedical Laboratory Science, Health and Society,
Malmö University, Malmö, Sweden
General Findings:
• Immune-deficiency results in increased neointimal
formation after arterial injury in mice.
• Humoral aspects of the immune system may be
involved in inhibiting neointimal formation:
B cells produce “natural antibodies” ?
Background
•T cell deficiency results in increased neointima in
injured rats (antibodies against T cell CD markers and
nu/nu rats)
Hansson, et al PNAS/Circ 1991
Remskar et al Circ Res. 2001
•CD40-CD40 ligand interaction mediates response to
arterial injury
Remskar et al Circ Res. 2001
•B cells implicated in bone-healing response as a
limiting factor
Marusic, et al LI 2000
•Homologous oxLDL immunization reduces
neointimal formation in injured hypercholesterolemic
rabbits
Nilsson et al JACC 1997
Arterial Injury
Activation of signaling cascades
Increased expression of inflammatory proteins/
medial SMC activation
Immune functions
physiologic IFN-γ
Immunoglobulins
Immune-deficiency
Vascular repair and Intimal formation
Hypothesis: B cells are involved in the response to
arterial injury.
Methods:
•Injure Rag-1 KO mice and compare to WT mice.
•“Rescue” Rag-1 KO mice with B cell reconstitution
from spleens of WT
•Repeat rescue with donor and recipients on western
diet
Arterial Cuff Injury
Tygon tube
Right carotid artery
harvest spleen from WT mice
squeeze through mesh to isolate cells
add paramagnetic beads
coated with T cell antibody
expose solution to magnetic field and
aspirate supe = negative selection of B cells
classify cell population
and/or spin and concentrate
Inject cells into Rag-1 KO mice via tail vein
Cell enrichment procedure
*p<0.05 vs. WT NC; †
p<0.05 vs. Rag NC
B cell reconstitution inhibits intimal formation
in Rag-1 KO mice fed normal chow
B cell reconstitution inhibits intimal formation
in Rag-1 KO mice fed western diet
*p<0.05 vs. WT HC; †
p<0.05 vs. Rag HC
WT HC Rag-KO Rag-1 KO Brec
Effect of B cell reconstitution on
intimal formation in injured Rag-1 KO mice
Neointimal stain for SM α-actin
(western diet-fed mice)
WT Rag-1 KO Rag-1 KO Brec
Mφ stain in arteries 21 days after injury
(western diet-fed mice)
WT Rag-1 KO Rag-1 KO Brec
IgM in injured arteries of western diet-fed mice
Left contra-lateral (uninjured) Injured right carotid artery
No reconstitution B cell reconstituted
WT
Rag-1 KO
WT
Rag-1 KO
Left contra-lateral (uninjured) Injured right carotid artery
No reconstitution B cell reconstituted
IgG in injured arteries of western diet-fed mice
Relative immunoglobulin levels
in B cell reconstituted mice
Summary of Study
•Neointimal formation after injury is inhibited in Rag-1
KO mice reconstituted with B cells regardless of diet.
•Immunoglobulin presence is increased in injured
arteries of WT mice and in B cell reconstituted Rag-1
KO mice.

Contenu connexe

Tendances

Patient-Specific Stem Cell Therapy for Inherited and Acquired Disorders with ...
Patient-Specific Stem Cell Therapy for Inherited and Acquired Disorders with ...Patient-Specific Stem Cell Therapy for Inherited and Acquired Disorders with ...
Patient-Specific Stem Cell Therapy for Inherited and Acquired Disorders with ...Society of International Business Fellows
 
Simvastatine, Edaravone and Dexamethasone protect against kainate - induced e...
Simvastatine, Edaravone and Dexamethasone protect against kainate - induced e...Simvastatine, Edaravone and Dexamethasone protect against kainate - induced e...
Simvastatine, Edaravone and Dexamethasone protect against kainate - induced e...SaritaVlez1
 
Combined Immunodeficiency
Combined ImmunodeficiencyCombined Immunodeficiency
Combined ImmunodeficiencySu Cho
 
Severe combined immunodeficiency
Severe combined immunodeficiencySevere combined immunodeficiency
Severe combined immunodeficiencykhawajamahnoor
 
Transplant pathology
Transplant pathologyTransplant pathology
Transplant pathologyEvith Pereira
 
Mechanism of tissue graft rejection
Mechanism of tissue graft rejectionMechanism of tissue graft rejection
Mechanism of tissue graft rejectionNilesh Chandra
 
Severe combined immunodeficiency [compatibility mode]
Severe combined immunodeficiency [compatibility mode]Severe combined immunodeficiency [compatibility mode]
Severe combined immunodeficiency [compatibility mode]asteinman
 
Transplant example presentation
Transplant example presentationTransplant example presentation
Transplant example presentationspeedr8cer82
 
Anshul trans rejection
Anshul trans rejectionAnshul trans rejection
Anshul trans rejectionAnshul Agrawal
 

Tendances (15)

039 mr contrast agents for vulnerable plaque imaging
039 mr contrast agents for vulnerable plaque imaging039 mr contrast agents for vulnerable plaque imaging
039 mr contrast agents for vulnerable plaque imaging
 
Patient-Specific Stem Cell Therapy for Inherited and Acquired Disorders with ...
Patient-Specific Stem Cell Therapy for Inherited and Acquired Disorders with ...Patient-Specific Stem Cell Therapy for Inherited and Acquired Disorders with ...
Patient-Specific Stem Cell Therapy for Inherited and Acquired Disorders with ...
 
Severe combined immunodeficiency - SCID
Severe combined immunodeficiency - SCIDSevere combined immunodeficiency - SCID
Severe combined immunodeficiency - SCID
 
Simvastatine, Edaravone and Dexamethasone protect against kainate - induced e...
Simvastatine, Edaravone and Dexamethasone protect against kainate - induced e...Simvastatine, Edaravone and Dexamethasone protect against kainate - induced e...
Simvastatine, Edaravone and Dexamethasone protect against kainate - induced e...
 
Combined Immunodeficiency
Combined ImmunodeficiencyCombined Immunodeficiency
Combined Immunodeficiency
 
Severe combined immunodeficiency
Severe combined immunodeficiencySevere combined immunodeficiency
Severe combined immunodeficiency
 
severe combined immunodeficiency
severe combined immunodeficiencysevere combined immunodeficiency
severe combined immunodeficiency
 
Transplant pathology
Transplant pathologyTransplant pathology
Transplant pathology
 
Mechanism of tissue graft rejection
Mechanism of tissue graft rejectionMechanism of tissue graft rejection
Mechanism of tissue graft rejection
 
Transplant rejection and GVD
Transplant rejection and GVD Transplant rejection and GVD
Transplant rejection and GVD
 
Effector Mechanisms in Transplant Rejection
Effector Mechanisms in Transplant RejectionEffector Mechanisms in Transplant Rejection
Effector Mechanisms in Transplant Rejection
 
Severe combined immunodeficiency [compatibility mode]
Severe combined immunodeficiency [compatibility mode]Severe combined immunodeficiency [compatibility mode]
Severe combined immunodeficiency [compatibility mode]
 
Secondary Immunodeficiency
Secondary ImmunodeficiencySecondary Immunodeficiency
Secondary Immunodeficiency
 
Transplant example presentation
Transplant example presentationTransplant example presentation
Transplant example presentation
 
Anshul trans rejection
Anshul trans rejectionAnshul trans rejection
Anshul trans rejection
 

En vedette

En vedette (19)

Nitrate tolerance
Nitrate toleranceNitrate tolerance
Nitrate tolerance
 
Non invasive imaging of the vulnerable plaque and the vulnerable patient ge ...
Non invasive imaging of  the vulnerable plaque and the vulnerable patient ge ...Non invasive imaging of  the vulnerable plaque and the vulnerable patient ge ...
Non invasive imaging of the vulnerable plaque and the vulnerable patient ge ...
 
Acc vp-org 3-02 stone
Acc vp-org 3-02 stoneAcc vp-org 3-02 stone
Acc vp-org 3-02 stone
 
Mi or scd in patients with very abnormal cardiac test results
Mi or scd in patients with very abnormal cardiac test resultsMi or scd in patients with very abnormal cardiac test results
Mi or scd in patients with very abnormal cardiac test results
 
251 computed tomographic coronary artery calcium
251 computed tomographic coronary artery calcium251 computed tomographic coronary artery calcium
251 computed tomographic coronary artery calcium
 
Mri of atherosclerotic plaque in apo e ko mice
Mri of atherosclerotic plaque in apo e ko  miceMri of atherosclerotic plaque in apo e ko  mice
Mri of atherosclerotic plaque in apo e ko mice
 
508 search for genomic and proteomic risk factors and protective factors asso...
508 search for genomic and proteomic risk factors and protective factors asso...508 search for genomic and proteomic risk factors and protective factors asso...
508 search for genomic and proteomic risk factors and protective factors asso...
 
A20 gene
A20 geneA20 gene
A20 gene
 
261 molecular genetics and micro arrays
261 molecular genetics and micro arrays261 molecular genetics and micro arrays
261 molecular genetics and micro arrays
 
510 does lxr links lipid metabolism to inflammation, or ppar
510 does lxr links lipid metabolism to inflammation, or ppar510 does lxr links lipid metabolism to inflammation, or ppar
510 does lxr links lipid metabolism to inflammation, or ppar
 
Libby
LibbyLibby
Libby
 
511 first steps towards understanding
511 first steps towards understanding511 first steps towards understanding
511 first steps towards understanding
 
Lodder
LodderLodder
Lodder
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)
 
Adeli 1 8
Adeli 1 8Adeli 1 8
Adeli 1 8
 
Macrophage uptake of cns1 1 d ( in vitro study)
Macrophage uptake of cns1 1 d ( in vitro study)Macrophage uptake of cns1 1 d ( in vitro study)
Macrophage uptake of cns1 1 d ( in vitro study)
 
Nir spectroscopy lodder- u of kentucky
Nir spectroscopy  lodder- u of kentuckyNir spectroscopy  lodder- u of kentucky
Nir spectroscopy lodder- u of kentucky
 
Introduction to nuclear magnetic resonance
Introduction to nuclear magnetic resonanceIntroduction to nuclear magnetic resonance
Introduction to nuclear magnetic resonance
 
Krucoff infra redx_aha_2002_x2
Krucoff infra redx_aha_2002_x2Krucoff infra redx_aha_2002_x2
Krucoff infra redx_aha_2002_x2
 

Similaire à Nilssonetal

Stem Cells - Biology ppt slides
Stem Cells - Biology ppt slidesStem Cells - Biology ppt slides
Stem Cells - Biology ppt slidesnihattt
 
gene therapy: What worked out and why everthing is not working
gene therapy: What worked out and why everthing is not workinggene therapy: What worked out and why everthing is not working
gene therapy: What worked out and why everthing is not workingSelestineSalema1
 
Paludisme grave : pourquoi doit-on développer des modèles in vitro sur le ter...
Paludisme grave : pourquoi doit-on développer des modèles in vitro sur le ter...Paludisme grave : pourquoi doit-on développer des modèles in vitro sur le ter...
Paludisme grave : pourquoi doit-on développer des modèles in vitro sur le ter...Institut Pasteur de Madagascar
 
Baker ectrims teaching slides
Baker ectrims teaching slidesBaker ectrims teaching slides
Baker ectrims teaching slidesBartsMSBlog
 
2015_Postdoc_symposium_poster
2015_Postdoc_symposium_poster2015_Postdoc_symposium_poster
2015_Postdoc_symposium_posterChi Y. Lo, Ph.D.
 
J immunol 2003-harshyne-2302-9
J immunol 2003-harshyne-2302-9J immunol 2003-harshyne-2302-9
J immunol 2003-harshyne-2302-9Elsa von Licy
 
Production of Monoclonal Antibodies and its application : Rituximab
Production of  Monoclonal Antibodies and its application : RituximabProduction of  Monoclonal Antibodies and its application : Rituximab
Production of Monoclonal Antibodies and its application : RituximabSakshi Saxena
 
Immunosuppression to prevent infection risk.pptx
Immunosuppression to prevent infection risk.pptxImmunosuppression to prevent infection risk.pptx
Immunosuppression to prevent infection risk.pptxRANJANEEMUTHU1
 
Immunosuppression to prevent infection risk.pptx
Immunosuppression to prevent infection risk.pptxImmunosuppression to prevent infection risk.pptx
Immunosuppression to prevent infection risk.pptxRANJANEEMUTHU1
 
Acute Allograft rejection in kidney transplantation 2017 Chaken
Acute Allograft rejection in kidney transplantation 2017 ChakenAcute Allograft rejection in kidney transplantation 2017 Chaken
Acute Allograft rejection in kidney transplantation 2017 ChakenCHAKEN MANIYAN
 
Pegs m abs in rx ms
Pegs m abs in rx msPegs m abs in rx ms
Pegs m abs in rx msBartsMSBlog
 
b-cells in periodontal diseases
b-cells in periodontal diseasesb-cells in periodontal diseases
b-cells in periodontal diseasesSonal Goyal
 
Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neu...
Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neu...Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neu...
Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neu...Gul Muneer
 

Similaire à Nilssonetal (20)

243 b cell
243 b cell243 b cell
243 b cell
 
Stem Cells - Biology ppt slides
Stem Cells - Biology ppt slidesStem Cells - Biology ppt slides
Stem Cells - Biology ppt slides
 
gene therapy: What worked out and why everthing is not working
gene therapy: What worked out and why everthing is not workinggene therapy: What worked out and why everthing is not working
gene therapy: What worked out and why everthing is not working
 
Paludisme grave : pourquoi doit-on développer des modèles in vitro sur le ter...
Paludisme grave : pourquoi doit-on développer des modèles in vitro sur le ter...Paludisme grave : pourquoi doit-on développer des modèles in vitro sur le ter...
Paludisme grave : pourquoi doit-on développer des modèles in vitro sur le ter...
 
Baker ectrims teaching slides
Baker ectrims teaching slidesBaker ectrims teaching slides
Baker ectrims teaching slides
 
238570.pptx
238570.pptx238570.pptx
238570.pptx
 
Vascular_Poster
Vascular_PosterVascular_Poster
Vascular_Poster
 
2015_Postdoc_symposium_poster
2015_Postdoc_symposium_poster2015_Postdoc_symposium_poster
2015_Postdoc_symposium_poster
 
J immunol 2003-harshyne-2302-9
J immunol 2003-harshyne-2302-9J immunol 2003-harshyne-2302-9
J immunol 2003-harshyne-2302-9
 
Production of Monoclonal Antibodies and its application : Rituximab
Production of  Monoclonal Antibodies and its application : RituximabProduction of  Monoclonal Antibodies and its application : Rituximab
Production of Monoclonal Antibodies and its application : Rituximab
 
Stem cells in cardiac care
Stem cells in cardiac careStem cells in cardiac care
Stem cells in cardiac care
 
Immunosuppression to prevent infection risk.pptx
Immunosuppression to prevent infection risk.pptxImmunosuppression to prevent infection risk.pptx
Immunosuppression to prevent infection risk.pptx
 
Immunosuppression to prevent infection risk.pptx
Immunosuppression to prevent infection risk.pptxImmunosuppression to prevent infection risk.pptx
Immunosuppression to prevent infection risk.pptx
 
Acute Allograft rejection in kidney transplantation 2017 Chaken
Acute Allograft rejection in kidney transplantation 2017 ChakenAcute Allograft rejection in kidney transplantation 2017 Chaken
Acute Allograft rejection in kidney transplantation 2017 Chaken
 
189 hsp 65
189 hsp 65189 hsp 65
189 hsp 65
 
189 hsp 65
189 hsp 65189 hsp 65
189 hsp 65
 
Esv2n49
Esv2n49Esv2n49
Esv2n49
 
Pegs m abs in rx ms
Pegs m abs in rx msPegs m abs in rx ms
Pegs m abs in rx ms
 
b-cells in periodontal diseases
b-cells in periodontal diseasesb-cells in periodontal diseases
b-cells in periodontal diseases
 
Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neu...
Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neu...Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neu...
Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neu...
 

Plus de Society for Heart Attack Prevention and Eradication

Plus de Society for Heart Attack Prevention and Eradication (20)

AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi PresentationAHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
 
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner PresentationAHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
 
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland PresentationAHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
 
AHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen PresentationAHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen Presentation
 
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka PresentationAHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
 
Vu lplaque1 pasterkamp
Vu lplaque1 pasterkampVu lplaque1 pasterkamp
Vu lplaque1 pasterkamp
 
Vulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patientVulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patient
 
Vulnerable plaque overview
Vulnerable plaque overviewVulnerable plaque overview
Vulnerable plaque overview
 
Vulnerable patient talk in poland
Vulnerable patient talk in polandVulnerable patient talk in poland
Vulnerable patient talk in poland
 
Vulnerable patient slides without movies
Vulnerable patient slides without moviesVulnerable patient slides without movies
Vulnerable patient slides without movies
 
Vulnerable patient mar 04
Vulnerable patient mar 04Vulnerable patient mar 04
Vulnerable patient mar 04
 
Vulnerable (thrombogenic blood
Vulnerable (thrombogenic bloodVulnerable (thrombogenic blood
Vulnerable (thrombogenic blood
 
Vuln shape aha 2005
Vuln shape aha 2005Vuln shape aha 2005
Vuln shape aha 2005
 
Vuln plaque poster burke
Vuln plaque poster burkeVuln plaque poster burke
Vuln plaque poster burke
 
Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-
 
Vp watch editorial_slide25
Vp watch editorial_slide25Vp watch editorial_slide25
Vp watch editorial_slide25
 
Vp watch editorial_slide25short-
Vp watch editorial_slide25short-Vp watch editorial_slide25short-
Vp watch editorial_slide25short-
 
Vp watch2002
Vp watch2002Vp watch2002
Vp watch2002
 
Vp symposium31602
Vp symposium31602Vp symposium31602
Vp symposium31602
 
Vpschoenhagen
VpschoenhagenVpschoenhagen
Vpschoenhagen
 

Dernier

METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 

Dernier (20)

METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 

Nilssonetal

  • 1. Inhibitory effect on arterial injury-induced neointimal formation by adoptive B cell transfer in Rag-1 KO mice P. Dimayuga, B. Cercek, S. Oguchi, G. N. Fredrikson, J. Yano, P. K. Shah, S. Jovinge, J. Nilsson Department of Medicine, Lund University, University Hospital MAS, Malmö, Sweden Atherosclerosis Research Center, Cedars-Sinai Medical Center, Los Angeles, California; Department of Biomedical Laboratory Science, Health and Society, Malmö University, Malmö, Sweden
  • 2. General Findings: • Immune-deficiency results in increased neointimal formation after arterial injury in mice. • Humoral aspects of the immune system may be involved in inhibiting neointimal formation: B cells produce “natural antibodies” ?
  • 3. Background •T cell deficiency results in increased neointima in injured rats (antibodies against T cell CD markers and nu/nu rats) Hansson, et al PNAS/Circ 1991 Remskar et al Circ Res. 2001 •CD40-CD40 ligand interaction mediates response to arterial injury Remskar et al Circ Res. 2001 •B cells implicated in bone-healing response as a limiting factor Marusic, et al LI 2000 •Homologous oxLDL immunization reduces neointimal formation in injured hypercholesterolemic rabbits Nilsson et al JACC 1997
  • 4. Arterial Injury Activation of signaling cascades Increased expression of inflammatory proteins/ medial SMC activation Immune functions physiologic IFN-γ Immunoglobulins Immune-deficiency Vascular repair and Intimal formation
  • 5. Hypothesis: B cells are involved in the response to arterial injury. Methods: •Injure Rag-1 KO mice and compare to WT mice. •“Rescue” Rag-1 KO mice with B cell reconstitution from spleens of WT •Repeat rescue with donor and recipients on western diet
  • 6. Arterial Cuff Injury Tygon tube Right carotid artery
  • 7. harvest spleen from WT mice squeeze through mesh to isolate cells add paramagnetic beads coated with T cell antibody expose solution to magnetic field and aspirate supe = negative selection of B cells classify cell population and/or spin and concentrate Inject cells into Rag-1 KO mice via tail vein Cell enrichment procedure
  • 8. *p<0.05 vs. WT NC; † p<0.05 vs. Rag NC B cell reconstitution inhibits intimal formation in Rag-1 KO mice fed normal chow
  • 9. B cell reconstitution inhibits intimal formation in Rag-1 KO mice fed western diet *p<0.05 vs. WT HC; † p<0.05 vs. Rag HC
  • 10. WT HC Rag-KO Rag-1 KO Brec Effect of B cell reconstitution on intimal formation in injured Rag-1 KO mice
  • 11. Neointimal stain for SM α-actin (western diet-fed mice) WT Rag-1 KO Rag-1 KO Brec
  • 12. Mφ stain in arteries 21 days after injury (western diet-fed mice) WT Rag-1 KO Rag-1 KO Brec
  • 13. IgM in injured arteries of western diet-fed mice Left contra-lateral (uninjured) Injured right carotid artery No reconstitution B cell reconstituted WT Rag-1 KO
  • 14. WT Rag-1 KO Left contra-lateral (uninjured) Injured right carotid artery No reconstitution B cell reconstituted IgG in injured arteries of western diet-fed mice
  • 15. Relative immunoglobulin levels in B cell reconstituted mice
  • 16. Summary of Study •Neointimal formation after injury is inhibited in Rag-1 KO mice reconstituted with B cells regardless of diet. •Immunoglobulin presence is increased in injured arteries of WT mice and in B cell reconstituted Rag-1 KO mice.